160 related articles for article (PubMed ID: 15475502)
1. Hindbrain contributions to anorexia.
Rinaman L
Am J Physiol Regul Integr Comp Physiol; 2004 Nov; 287(5):R1035-6. PubMed ID: 15475502
[No Abstract] [Full Text] [Related]
2. Role of GLP-1 in meal-taking.
Hellström PM; Näslund E
Appetite; 1999 Apr; 32(2):276. PubMed ID: 10097034
[No Abstract] [Full Text] [Related]
3. Central glucagon-like peptide-I in the control of feeding.
Gunn I; O'Shea D; Turton MD; Beak SA; Bloom SR
Biochem Soc Trans; 1996 May; 24(2):581-4. PubMed ID: 8736807
[No Abstract] [Full Text] [Related]
4. Intracerebroventricular injection of fusaric acid attenuates the anorexia by glucagon-like peptide-1 in the neonatal chick.
Bungo T; Kawakami SI; Ohgushi A; Sashihara K; Saito N; Sugahara K; Hasegawa S; Denbow DM; Furuse M
Pharmacol Biochem Behav; 2001; 70(2-3):251-5. PubMed ID: 11701195
[TBL] [Abstract][Full Text] [Related]
5. Learning from the gut.
Mattson MP; Perry T; Greig NH
Nat Med; 2003 Sep; 9(9):1113-5. PubMed ID: 12949521
[No Abstract] [Full Text] [Related]
6. Glucagon-like peptide-1. Gastrointestinal function and possible mechanism of action.
Wettergren A
Dan Med Bull; 2001 Feb; 48(1):19-28. PubMed ID: 11258148
[No Abstract] [Full Text] [Related]
7. GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats.
Rinaman L; Rothe EE
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R99-106. PubMed ID: 12069935
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1, satiety and appetite control.
Blundell JE; Naslund E
Br J Nutr; 1999 Apr; 81(4):259-60. PubMed ID: 10999011
[No Abstract] [Full Text] [Related]
9. The incretins--outdated terminology in man?
Edwards CM; Bloom SR
Diabetologia; 1999 Sep; 42(9):1148-9. PubMed ID: 10447529
[No Abstract] [Full Text] [Related]
10. [Glucagon-like peptide 1--a new physiologic mediator of satiety?].
Gallwitz B; Schmidt WE
Z Gastroenterol; 1996 Nov; 34(11):775-7. PubMed ID: 9045540
[No Abstract] [Full Text] [Related]
11. The glucagon-like peptides: a double-edged therapeutic sword?
Perry T; Greig NH
Trends Pharmacol Sci; 2003 Jul; 24(7):377-83. PubMed ID: 12871671
[No Abstract] [Full Text] [Related]
12. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide containing pathways in the regulation of feeding behaviour.
Tang-Christensen M; Vrang N; Larsen PJ
Int J Obes Relat Metab Disord; 2001 Dec; 25 Suppl 5():S42-7. PubMed ID: 11840214
[TBL] [Abstract][Full Text] [Related]
14. The hypothalamus is involved in the anorexic effect of glucagon-like peptide-1 in chicks.
Tachibana T; Hirofuji K; Matsumoto M; Furuse M; Hasegawa S; Yoshizawa F; Sugahara K
Comp Biochem Physiol A Mol Integr Physiol; 2004 Jan; 137(1):183-8. PubMed ID: 14720603
[TBL] [Abstract][Full Text] [Related]
15. Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1.
Hellström PM; Näslund E
Physiol Behav; 2001; 74(4-5):735-41. PubMed ID: 11790437
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide 1 (GLP-1) and eating.
Gutzwiller JP; Degen L; Heuss L; Beglinger C
Physiol Behav; 2004 Aug; 82(1):17-9. PubMed ID: 15234584
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.
Meier JJ; Gallwitz B; Schmidt WE; Nauck MA
Eur J Pharmacol; 2002 Apr; 440(2-3):269-79. PubMed ID: 12007541
[TBL] [Abstract][Full Text] [Related]
18. Effect of rat glicentin on intestinal adaptation in small intestine-resected rats.
Hirotani Y; Taki M; Kataoka K; Kurokawa N; Satoh T; Sasaki K; Yanaihara C; Luo WQ; Yanaihara N
Ann N Y Acad Sci; 1998 Dec; 865():601-5. PubMed ID: 9928077
[No Abstract] [Full Text] [Related]
19. A new Alzheimer's disease interventive strategy: GLP-1.
Perry TA; Greig NH
Curr Drug Targets; 2004 Aug; 5(6):565-71. PubMed ID: 15270203
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
Edwards CM; Todd JF; Mahmoudi M; Wang Z; Wang RM; Ghatei MA; Bloom SR
Diabetes; 1999 Jan; 48(1):86-93. PubMed ID: 9892226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
